MXB-009（Maxwell Biosciences）

N/A

Report date: 2023/01/09 16:48:46
NME

Base Information

Drug NameMXB-009（Maxwell Biosciences）
Drug Alias NameMXB-9MXB-009
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionEnvelope glycoprotein inhibitors
TargetsEnvelope glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Herpes Labialis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMaxwell Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesMaxwell Biosciences Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Herpes Labialis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A